GenMark Dx's mission is to become the market leader in providing high value, simple to perform, clinically relevant multiplex molecular tests to aid in the diagnosis of disease and the selection and dosing of therapies.
For investor information, please contact IR@genmarkdx.com.
May 15, 2013 at 2:20 PM PT
Bank of America Merrill Lynch 2013 Healthcare Conference
May 8, 2013 at 1:15 PM PT
GenMark Diagnostics First Quarter Earnings Conference Call